Supporting decision-making capacity in oncology. Development and piloting of a multimodal intervention

Supporting decision-making capacity in oncology. Development and piloting of a multimodal intervention - Onco:cide

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029632

Enrollment

130

Registered

2023-05-30

Start date

2023-07-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Squamous cell carcinoma of the oesophagus stage IV

Interventions

Group 1: The intervention is in the development phase and will be completed in December 2023. 1) Modified, target group-specific, medical informed consend documents(including shortening, visualization

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. indication of a systemic therapy 2. understanding of the German language

Exclusion criteria

Exclusion criteria: 1. lack of or unclear capacity to give consent or presence of a legal guardian 2. lack of ability to speak, e.g. due to severe mucositis 3. patient is in the dying phase

Design outcomes

Primary

Measure	Time frame
Decision-making capacity at T0 and T1 via MacArthur Competence Assesment Tool for Treatment (MacCAT-T)	—

Secondary

Measure	Time frame
1. decisional conflict at T0 and T1 via Decisional Conflict Scale (DCS) 2. anxiety and depression an T0 und T1 via Hospital Anxiety and Depression Scale (HADS-D) 3. acceptance of the intervention an T1 via Acceptability Intervention Measure (AIM)	—

Countries

Germany

Contacts

Public ContactStephan Nadolny

Institut für Geschichte und Ethik der Medizin, Martin-Luther-Universität Halle-Wittenberg

stephan.nadolny@medizin.uni-halle.de+49 49 345 557 3554

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 6, 2026